ArticleAmerican journal of translational research2025
Neutrophil-to-lymphocyte ratio and CD40 as diagnostic biomarkers for systemic lupus erythematosus and its disease activity.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Application Value of Blood Routine-Derived Indices for the Evaluation of Disease Activity in Systemic Lupus Erythematosus.Clinical medicine insights. Arthritis and musculoskeletal disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the diagnostic value of the neutrophil-to-lymphocyte ratio (NLR), CD40, and other clinical indicators in systemic lupus erythematosus (SLE).
methodsA retrospective study was conducted with 158 SLE patients treated at Xijing Hospital. The SLE group was divided into an active group (n = 95) and a low-activity group (n = 63). A control group consisting of 105 healthy individuals was also included. NLR, CD40, and other relevant clinical indicators were collected from the medical record system. The diagnostic or differential value of these indicators for SLE or disease activity (high vs. low) was assessed using ROC curves. Pearson correlation coefficients were used to examine the correlations between NLR, CD40, C-reactive protein (CRP), red blood cell distribution width (RDW), monocyte-to-lymphocyte ratio (MLR), and the SLE Disease Activity Index (SLEDAI) score.
resultsNLR and CD40 levels were significantly elevated in the SLE group (P < 0.001), with respective AUC values for diagnosing SLE of 0.917 and 0.907. NLR and CD40 levels in the SLE group were positively correlated with CRP and RDW, and negatively correlated with MLR (both P < 0.001). Furthermore, NLR and CD40 levels in the active SLE group were significantly higher than those in the low-activity group (P < 0.001), with AUC values for diagnosing disease activity of 0.902 and 0.904, respectively. SLEDAI scores were positively correlated with NLR and CD40 levels (P < 0.001).
conclusionsBoth NLR and CD40 demonstrate high diagnostic value for SLE and disease activity assessment, suggesting their potential for clinical application in SLE diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.